2024/10/18 17:32:11 | |
---|---|
Price | |
422.20 EUR | |
Difference | -0.75% (-3.20) |
ISIN | US45168D1046 |
Symbol | IDXX |
Exchange | Vienna Stock Exchange |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 34,791 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 419.60 EUR (22) |
Ask (Ask size) | 424.70 EUR (22) |
Open | 424.10 EUR |
High | 424.80 EUR |
Low | 422.20 EUR |
Close (prev. day) | 425.40 EUR |
VWAP | 458.13 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 4 |
Last size | 0 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/09/27 | Global Equity Ratings | ||
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings |
2024/10/18 17:32:11 | |
---|---|
Price | |
422.20 EUR | |
Difference | -0.75% (-3.20) |
ISIN | US45168D1046 |
Symbol | IDXX |
Exchange | Vienna Stock Exchange |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 34,791 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 419.60 EUR (22) |
Ask (Ask size) | 424.70 EUR (22) |
Open | 424.10 EUR |
High | 424.80 EUR |
Low | 422.20 EUR |
Close (prev. day) | 425.40 EUR |
VWAP | 458.13 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 4 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | -6.49% | +3.18% | -22.42% |
Perf (abs.) | -29.30 | +13.00 | -122.00 |
Beta | 0.94 | 1.11 | 1.27 |
Volatility | 27.85 | 28.49 | 32.11 |
Ø price 5 days | Ø volume 5 days (pcs.) | 431.10 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 444.56 EUR (0) |
Ø price 100 days | Ø volume 100 days (pcs.) | 445.55 EUR (0) |
Ø price 250 days | Ø volume 250 days (pcs.) | 464.08 EUR (1) |
YTD High | date | 535.60 EUR (2024/03/01) |
YTD Low | date | 415.10 EUR (2024/08/06) |
52 Weeks High | date | 535.60 EUR (2024/03/01) |
52 Weeks Low | date | 359.10 EUR (2023/11/01) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2024/10/18 | 17:35 | 421.50 EUR | 0.00 | 2 |
Vienna Stock Exchange | 2024/10/18 | 17:32 | 422.20 EUR | 0.00 | 4 |
Tradegate | 2024/10/18 | 22:26 | 421.40 EUR | 0.03 | 5 |
Stuttgart | 2024/10/18 | 21:31 | 420.80 EUR | 0.01 | 8 |
Nasdaq | 2024/10/18 | 22:00 | 457.74 USD | 342.19 | 20,745 |
Munich | 2024/10/18 | 08:01 | 426.10 EUR | 0.00 | 2 |
London Stock Exchange | 2024/10/18 | 16:50 | 457.86 USD | 0.01 | 4 |
Hanover | 2024/10/18 | 17:25 | 422.00 EUR | 0.00 | 4 |
Frankfurt | 2024/10/18 | 10:15 | 422.60 EUR | 0.10 | 1 |
Duesseldorf | 2024/10/18 | 19:31 | 421.20 EUR | 0.00 | 5 |
Berlin | 2024/10/18 | 08:08 | 422.20 EUR | 0.00 | 2 |
IDEXX LABORATORIES INC. |
- - |
One IDEXX Drive - 04092-2040 Westbrook |
Telefon: +1-207-556-0300 |
Fax: +1-207-556-4346 |
E-mail: - |
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other. The CAG segment provides diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment offers innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water. The LPD segment develops diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food. The Other segment is composed of products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983, and is headquartered in Westbrook, ME. |
Lawrence Kingsley | Chairman of Board of Directors |
Asha Collins | Member of Board of Directors |
Sophie Vandebroek | Member of Board of Directors |
Stuart Essig | Member of Board of Directors |
Bruce Claflin | Member of Board of Directors |
Daniel Junius | Member of Board of Directors |
Irene Britt | Member of Board of Directors |
Jonathan Ayers | Member of Board of Directors |
M. Szostak | Member of Board of Directors |
Sam Samad | Member of Board of Directors |
Jay Mazelsky | Chairman of Managing Board |
Brian P. McKeon | Member of Executive Committee |
James F. Polewaczyk | Member of Executive Committee |
Ken Grady | Member of Executive Committee |
Martin Smith | Member of Executive Committee |
Michael P. Johnson | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).
The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.
Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended), citizen/resident of Australia, Canada, Great Britain and Japan. For this reason, the distribution or redistribution of the information, materials and products into United States, Australia, Canada, Great Britain and Japan or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited.
The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.
The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.
By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.